straight to the negatives mate... sad bloke..
You must love negativity that its all you look for.
I like the statement:
Following CE and FDA clearance, cardiocel is seeing increasing adoption as the TISSUE OF CHOICE for the repair of chd, MORE COMPLEX HEART DEFECTS and HEART VALVE REPAIR.
One panelist for us at the symposium is someone from Royal Brompton Hospital, might check that one out.
thanks for shaking it, page-86
-
- There are more pages in this discussion • 17 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |